Search results for "longitudinal"

showing 10 items of 1501 documents

Measurement of pion and proton response and longitudinal shower profiles up to 20 nuclear interaction lengths with the ATLAS Tile calorimeter

2010

The response of pions and protons in the energy range of 20–180 GeV, produced at CERN's SPS H8 test-beam line in the ATLAS iron–scintillator Tile hadron calorimeter, has been measured. The test-beam configuration allowed the measurement of the longitudinal shower development for pions and protons up to 20 nuclear interaction lengths. It was found that pions penetrate deeper in the calorimeter than protons. However, protons induce showers that are wider laterally to the direction of the impinging particle. Including the measured total energy response, the pion-to-proton energy ratio and the resolution, all observations are consistent with a higher electromagnetic energy fraction in pion-indu…

Nuclear and High Energy PhysicsProtonTest-beamPion–proton responsePhysics::Instrumentation and DetectorsHadronMonte Carlo methodNuclear TheoryHadronic shower development01 natural sciencesElectromagnetic radiationPartícules (Física nuclear)Nuclear physicsPion0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Detectors and Experimental Techniques010306 general physicsNuclear ExperimentInstrumentationMonte Carlo simulationGEANT4Detectors de radiacióPhysicsCalorimeterLarge Hadron Collider010308 nuclear & particles physicsATLASLongitudinal shower profile for hadronsScintillation counterPhysics::Accelerator PhysicsHigh Energy Physics::ExperimentParametrization
researchProduct

Measurements of $R^{d}-R^{p}$ and $R^{Ca}-R^{C}$ in deep inelastic muon scattering

1992

Results are presented on the difference in R, the ratio of longitudinally to transversely polarised virtual photon absorption cross sections, for the deuteron and the proton. They are obtained by c ...

Nuclear and High Energy PhysicsProtonmuon nucleus: deep inelastic scatteringNuclear Theorypolarization: longitudinaldeep inelastic scattering: muon deuteronVirtual particlecross section: ratiophoton: absorptionElementary particlemuon deuteron: deep inelastic scattering530Nuclear physicsabsorption: photondeep inelastic scattering: muon ppolarization: transverseHIGH STATISTICS MEASUREMENT; R=SIGMA-L/SIGMA-T; HIGH Q2Nuclear ExperimentAbsorption (electromagnetic radiation)deep inelastic scattering: muon nucleus90: 200: 280 GeVPhysicsHIGH STATISTICS MEASUREMENTMuoncalciumScatteringcarbonstructure function: ratioR=SIGMA-L/SIGMA-TCERN SPSlongitudinal: polarizationParticle scatteringDeuteriummuon p: deep inelastic scatteringHIGH Q2Physics::Accelerator Physicstransverse: polarizationAtomic physicsParticle Physics - Experimentexperimental results
researchProduct

Association Between Long-Term Job Strain and Metabolic Syndrome Factor Across Sex and Occupation

2006

The present study investigated whether long-term job strain increases the prevalence of risk for metabolic syndrome, a cluster of risk factors for cardiovascular diseases, across sex and occupation. The participants (64 men, 62 women) were drawn from the Jyväskylä Longitudinal Study of Personality and Social Development, Finland. Job strain was measured by a combination of high job demands and low job control ( Karasek, 1979 ) at ages 36 and 42. Metabolic syndrome was measured at age 42. The results indicated that both sex and occupational group moderated the association between long-term job strain and the metabolic syndrome factor but in an unexpected way. In women, low long-term job str…

Occupational groupLongitudinal studyJob strainJob controlmedia_common.quotation_subject05 social sciencesmedicine.diseaseDisease clusterDevelopmental psychology03 medical and health sciences0302 clinical medicine0502 economics and businessmedicinePersonality030212 general & internal medicineMetabolic syndromePsychologyAssociation (psychology)050203 business & managementBiological PsychiatryGeneral Psychologymedia_commonDemographyJournal of Individual Differences
researchProduct

Life-Space Mobility in Parkinson's Disease: Associations with Motor and Non-Motor Symptoms.

2019

Background To describe life-space mobility and explore associations of motor and non-motor symptoms with life-space mobility in people with Parkinson’s disease (PD). Methods About 164 community-dwelling persons with PD (mean age 71.6 years, 64.6% men) received a postal survey and a subsequent home visit. Motor assessments included perceived walking difficulties (Walk-12G), mobility (Timed Up and Go test), motor symptoms (UPDRS-III), and freezing of gait (item 3, FOG-Qsa). Non-motor symptoms included depressive symptoms (GDS-15), pain, fatigue (NHP-EN), and global cognition (MoCA). Life-space mobility was assessed with the life-space assessment (LSA). Calculations included composite score (r…

Occupational therapyMaleAgingmedicine.medical_specialtyNeurologyParkinson's diseaseParkinsonin tautiDiseaseTimed Up and Go testelämänlaatuMotor Activity03 medical and health sciences0302 clinical medicineliikuntakykyparticipationMedicineassistive devicesHumans030212 general & internal medicineLongitudinal StudiesMobility LimitationFatigueosallistuminenAgedAged 80 and overbusiness.industryConfoundingCognitionParkinson Diseaseta3142apuvälineetMiddle Agedmedicine.diseaseGaitmobilityliikkuvuusPhysical therapyLinear ModelsFemaleIndependent LivingGeriatrics and Gerontologybusinesshuman activities030217 neurology & neurosurgerywalking difficultiesThe journals of gerontology. Series A, Biological sciences and medical sciences
researchProduct

Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS

2020

ObjectiveWe applied longitudinal 3T MRI and advanced computational models in 2 independent cohorts of patients with early MS to investigate how white matter (WM) lesion distribution and cortical atrophy topographically interrelate and affect functional disability.MethodsClinical disability was measured using the Expanded Disability Status Scale Score at baseline and at 1-year follow-up in a cohort of 119 patients with early relapsing-remitting MS and in a replication cohort of 81 patients. Covarying patterns of cortical atrophy and baseline lesion distribution were extracted by parallel independent component analysis. Predictive power of covarying patterns for disability progression was tes…

OncologyAdultMalemedicine.medical_specialtySupport Vector Machine41Article312LesionWhite matterText miningMultiple Sclerosis Relapsing-RemittingInternal medicineCerebellumMedicineHumansLongitudinal StudiesCerebral CortexExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisMagnetic resonance imagingMiddle Agedmedicine.diseasePrognosisMagnetic Resonance ImagingWhite MatterHyperintensitymedicine.anatomical_structureNeurologyCohortDisease ProgressionFemaleNeurology (clinical)medicine.symptomAtrophybusinessNeurology® Neuroimmunology & Neuroinflammation
researchProduct

Breast-cancer predisposition in multiple endocrine neoplasia type 1

2014

Women with multiple endocrine neoplasia type 1 related to mutations in the gene encoding menin (MEN1) have approximately twice the risk of breast cancer as do women in the general population.

OncologyAdultRiskcongenital hereditary and neonatal diseases and abnormalitiesendocrine systemmedicine.medical_specialtyendocrine system diseasesGenotypePopulationVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Breast Neoplasmsmedicine.disease_causeArticleBreast cancerSDG 3 - Good Health and Well-beingInternal medicineProto-Oncogene ProteinsGenotypemedicineCarcinomaMultiple Endocrine Neoplasia Type 1HumansMEN1Genetic Predisposition to DiseaseLongitudinal StudiesMultiple endocrine neoplasiaeducationGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)GeneNetherlandsMutationeducation.field_of_studybusiness.industryCarcinoma Ductal BreastGeneral MedicineMiddle Agedmedicine.diseaseCarcinoma PapillaryImmunologyMutationFemalebusiness
researchProduct

The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicent…

2016

Elderly breast cancer patients are affected by poorer quality of life (QoL) compared to younger patients. Because QoL has a relevant impact on guideline-adherent treatment, elderly breast cancer patients are often undertreated, especially with regard to adjuvant chemotherapy, and overall survival is decreased. Thus, understanding the impact of chemotherapy on QoL in elderly patients is crucial. This study compared QoL in patients aged 65 years and 65 to 70 years receiving adjuvant chemotherapy as a secondary outcome in the prospective randomized multicenter ADEBAR trial.Patients with lymph node-positive breast cancer were prospectively randomized for either sequential anthracycline-taxane o…

OncologyCancer ResearchDocetaxel0302 clinical medicineQuality of lifeSurveys and QuestionnairesAntineoplastic Combined Chemotherapy ProtocolsMulticenter Studies as TopicAnthracyclinesLongitudinal StudiesProspective Studies030212 general & internal medicineYoung adultProspective cohort studyAntibiotics AntineoplasticAge FactorsMiddle AgedhumanitiesOncologyDocetaxelChemotherapy Adjuvant030220 oncology & carcinogenesisPractice Guidelines as TopicFemaleTaxoidsFluorouracilmedicine.drugEpirubicinAdultBridged-Ring Compoundsmedicine.medical_specialtyAdolescentCyclophosphamideBreast NeoplasmsYoung Adult03 medical and health sciencesBreast cancerInternal medicinemedicineHumansCyclophosphamideAgedEpirubicinbusiness.industryCancermedicine.diseaseClinical Trials Phase III as TopicQuality of LifePatient CompliancebusinessClinical Breast Cancer
researchProduct

Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutant melanoma: First data of the multicenter, m…

2021

9555 Background: For the treatment of advanced BRAFV600-mutated melanoma, targeted therapy (BRAF/MEK-inhibition) is a standard of care. Encorafenib + binimetinib (EB) were approved in the EU in Sep 2018 and in Switzerland in Nov 2019, based on positive results from COLUMBUS (NCT01909453), with a median progression-free survival (PFS) of 14.9 mo (4-year PFS: 26%) and overall survival (OS) of 33.6 mo (4-year OS: 39%). As data from controlled trials are based on selected populations, BERINGMELANOMA investigates the use of EB under real-world conditions in a broader population. Methods: BERINGMELANOMA is an ongoing, multi-national, multi-center, prospective, longitudinal, non-interventional st…

OncologyCancer Researchmedicine.medical_specialtyLongitudinal studyStandard of carebusiness.industrymedicine.medical_treatmentMelanomaMedizinLocally advancedBinimetinibmedicine.diseaseTargeted therapychemistry.chemical_compoundOncologychemistryInternal medicineNon interventionalMedicineIn patientbusinessJournal of Clinical Oncology
researchProduct

Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study

2013

Objectives: Traditional clinical risk factors are associated with inflammation cross-sectionally, but associations of longitudinal variation in inflammatory biomarkers with corresponding changes in clinical risk factors are incompletely described. We sought to analyze clinical factors associated with change in inflammation in the community.Methods: We studied 3013 Framingham Offspring (n = 2735) and Omni Cohort (n = 278) participants (mean age 59 years, 55% women, 9% ethnic/racial minority) who attended two consecutive examination cycles (mean 6.7 years apart). We selected ten inflammatory biomarkers representing distinctive biological functions: C-reactive protein (CRP), intercellular adhe…

OncologyMaleBLOOD-PRESSUREIsoprostanesFramingham Heart StudyRisk FactorsMyocardial infarctionOXIDATIVE STRESSskin and connective tissue diseasesChemokine CCL2Biological markersbiologyLongitudinal studiesMiddle AgedIntercellular Adhesion Molecule-1Inflammatory biomarkersC-REACTIVE PROTEINP-SelectinADIPOSE-TISSUEMassachusettsCardiovascular DiseasesCARDIOVASCULAR-DISEASEFemalemedicine.symptomCardiology and Cardiovascular MedicineVasculitisVasculitismedicine.medical_specialtyInflammationArticleInternal medicinemedicineHumansReceptors Tumor Necrosis Factor Type IIInterleukin 6AgedInflammationbusiness.industryInterleukin-6PERIPHERAL ARTERIAL-DISEASEC-reactive proteinOsteoprotegerinADHESION MOLECULE-1medicine.diseasePHOSPHOLIPASE A(2)Blood pressurePLASMA-CONCENTRATIONMYOCARDIAL-INFARCTIONImmunology1-Alkyl-2-acetylglycerophosphocholine Esterasebiology.proteinsense organsbusinessBiomarkers
researchProduct

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.

2020

[Purpose] Assessing measurable residual disease (MRD) has become standard with many tumors, but the clinical meaning of MRD in multiple myeloma (MM) remains uncertain, particularly when assessed by next-generation flow (NGF) cytometry. Thus, we aimed to determine the applicability and sensitivity of the flow MRD-negative criterion defined by the International Myeloma Working Group (IMWG).

OncologyMaleCancer Researchmedicine.medical_specialtyNeoplasm ResidualDiseaseResidualTHERAPYDexamethasoneFlow cytometryBortezomib03 medical and health sciences0302 clinical medicineInternal medicinehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansMeaning (existential)Longitudinal StudiesLenalidomideMultiple myeloma030304 developmental biologyCONSOLIDATIONRandomized Controlled Trials as Topic0303 health sciencesCOMPLETE RESPONSEmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseFlow Cytometry3. Good healthClinical trialPROGNOSTIC VALUEbody regionsMRDOncologyClinical Trials Phase III as Topic030220 oncology & carcinogenesisFemaleSTEM-CELL TRANSPLANTbusinessMultiple MyelomaDARATUMUMABJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct